Xeris Biopharma Holdings, Inc. Quarterly Amortization of Intangible Assets in USD from Q1 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.
Summary
Xeris Biopharma Holdings, Inc. quarterly/annual Amortization of Intangible Assets history and growth rate from Q1 2021 to Q3 2024.
  • Xeris Biopharma Holdings, Inc. Amortization of Intangible Assets for the quarter ending September 30, 2024 was $2.71M, unchanged year-over-year.
  • Xeris Biopharma Holdings, Inc. Amortization of Intangible Assets for the twelve months ending September 30, 2024 was $10.8M, unchanged year-over-year.
  • Xeris Biopharma Holdings, Inc. annual Amortization of Intangible Assets for 2023 was $10.8M, unchanged from 2022.
  • Xeris Biopharma Holdings, Inc. annual Amortization of Intangible Assets for 2022 was $10.8M, a 1871% increase from 2021.
  • Xeris Biopharma Holdings, Inc. annual Amortization of Intangible Assets for 2021 was $550K.
Amortization of Intangible Assets, Trailing 12 Months (USD)
Amortization of Intangible Assets, Quarterly (USD)
Amortization of Intangible Assets, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $10.8M $2.71M $0 0% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-08
Q2 2024 $10.8M $2.71M $0 0% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $10.8M $2.71M $0 0% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $10.8M $2.71M $0 0% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-06
Q3 2023 $10.8M $2.71M $0 0% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-08
Q2 2023 $10.8M $2.71M $0 0% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $10.8M $2.71M $0 0% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $10.8M $2.71M +$2.16M +393% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-06
Q3 2022 $8.68M $2.71M +$2.71M Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 $5.97M $2.71M +$2.71M Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.26M $2.71M +$2.71M Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $550K $550K Oct 1, 2021 Dec 31, 2021 10-K 2024-03-06
Q3 2021 $0 Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $0 Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $0 Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-11
* An asterisk sign (*) next to the value indicates that the value is likely invalid.